(Q33453053)
Statements
Patients with rheumatoid arthritis treated with tumour necrosis factor antagonists increase their participation in the workforce: potential for significant long-term indirect cost gains (data from a population-based registry) (English)
J Augustsson
C Cullinane-Carli
R F van Vollenhoven